Tilray Inc (NASDAQ:TLRY - Get Free Report) shares rose 2.6% during mid-day trading on Wednesday . The stock traded as high as $0.44 and last traded at $0.43. Approximately 6,391,842 shares were traded during trading, a decline of 78% from the average daily volume of 28,479,934 shares. The stock had previously closed at $0.42.
Analysts Set New Price Targets
A number of brokerages recently weighed in on TLRY. Roth Capital restated a "neutral" rating on shares of Tilray in a report on Monday, April 14th. Canaccord Genuity Group upped their price objective on Tilray from $2.00 to $3.00 and gave the stock a "buy" rating in a research report on Monday, January 13th. Finally, Piper Sandler lowered their target price on Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a research note on Wednesday, April 9th.
Check Out Our Latest Report on TLRY
Tilray Trading Down 3.5 %
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The stock has a market cap of $429.77 million, a price-to-earnings ratio of -1.42 and a beta of 1.95. The business's 50 day moving average is $0.56 and its 200 day moving average is $1.00.
Tilray (NASDAQ:TLRY - Get Free Report) last issued its earnings results on Tuesday, April 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company had revenue of $185.78 million during the quarter, compared to analyst estimates of $213.38 million. As a group, equities analysts expect that Tilray Inc will post -0.2 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Tilray
Several large investors have recently modified their holdings of the company. Tidal Investments LLC boosted its stake in Tilray by 9.2% during the 4th quarter. Tidal Investments LLC now owns 10,595,264 shares of the company's stock worth $14,092,000 after purchasing an additional 889,086 shares during the period. Quinn Opportunity Partners LLC increased its position in Tilray by 108.0% in the 4th quarter. Quinn Opportunity Partners LLC now owns 1,618,080 shares of the company's stock valued at $2,152,000 after acquiring an additional 840,000 shares during the period. Virtu Financial LLC purchased a new stake in Tilray during the 4th quarter valued at approximately $1,029,000. Dimensional Fund Advisors LP lifted its position in Tilray by 54.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,172,935 shares of the company's stock worth $2,890,000 after acquiring an additional 769,569 shares during the period. Finally, Millennium Management LLC acquired a new stake in Tilray during the 4th quarter worth approximately $879,000. 9.35% of the stock is owned by institutional investors and hedge funds.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
